tiprankstipranks
Trending News
More News >

Biofrontera AG Pre-announces H1 2025 Financial Report

Story Highlights
Biofrontera AG Pre-announces H1 2025 Financial Report

Don’t Miss TipRanks’ Half-Year Sale

Biofrontera ( (DE:B8FK) ) just unveiled an announcement.

Biofrontera AG has announced the pre-release of its financial report for the first half of 2025, covering the period from January 1 to June 30, 2025. The report is scheduled to be published on September 30, 2025, and will be accessible on the company’s website. This announcement is part of Biofrontera’s compliance with financial disclosure regulations, potentially impacting investor relations and market perception.

More about Biofrontera

Biofrontera AG is a company operating in the pharmaceutical industry, focusing on the development and commercialization of dermatological products. It is listed on several stock exchanges including Dusseldorf, Frankfurt, Berlin, Munich, Stuttgart, and Tradegate.

Average Trading Volume: 1,633

Technical Sentiment Signal: Sell

Current Market Cap: €15.19M

Find detailed analytics on B8FK stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1